Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
Dorward J., Sookrajh Y., Lessells R., Bulo E., Bodley N., Singh L., Moodley P., Samsunder N., Drain PK., Hayward G., Butler CC., Garrett N.
Supplemental Digital Content is Available in the Text.